Nyxoah Archives | Be Korea-savvy
Nyxoah Reports First Quarter 2022 Financial and Operating Results

Nyxoah Reports First Quarter 2022 Financial and Operating Results

Mont-Saint-Guibert, Belgium, May 10 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the first quarter of 2022.   First Quarter 2022 Financial and Operating Highlights Generated revenue of [...]

Nyxoah Reports First Quarter 2022 Financial and Operating Results

Nyxoah Reports First Quarter 2022 Financial and Operating Results

Mont-Saint-Guibert, Belgium, May 9 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the first quarter of 2022.   First Quarter 2022 Financial and Operating Highlights Generated revenue of [...]

Invitation to Attend the Annual and the Extraordinary Shareholders’ Meetings of the Company to be Held on June 8, 2022

Invitation to Attend the Annual and the Extraordinary Shareholders’ Meetings of the Company to be Held on June 8, 2022

REGULATED INFORMATION May 6, 2022, 7:00am CET / 1:00am ET NYXOAH SA (Euronext Brussels: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium (hereinafter the “Company”) Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 8, 2022 The board of directors of the Company is pleased to invite [...]

Nyxoah Nominates Raymond Cohen and Virginia Kirby for Appointment to Its Board of Directors

Nyxoah Nominates Raymond Cohen and Virginia Kirby for Appointment to Its Board of Directors

Mont-Saint-Guibert, Belgium, May 6 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the nomination of Raymond Cohen and Virginia Kirby for appointment to the Company’s Board of Directors, pending approval by [...]

Nyxoah to Release First Quarter 2022 Financial Results on May 9 and Host Conference Call on May 10, 2022

Nyxoah to Release First Quarter 2022 Financial Results on May 9 and Host Conference Call on May 10, 2022

Mont-Saint-Guibert, Belgium, April 28 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the first quarter of 2022 on Monday, May 9, 2022, after [...]

Nyxoah Reports Full Year 2021 Operating and Financial Results

Nyxoah Reports Full Year 2021 Operating and Financial Results

Mont-Saint-Guibert, Belgium, March 24 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the full year ending December 31, 2021. Full Year 2021 Operational and Financial Highlights [...]

BETTER SLEEP Achieves Primary Endpoint Across All Patient Cohorts

BETTER SLEEP Achieves Primary Endpoint Across All Patient Cohorts

Mont-Saint-Guibert, Belgium, March 14 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today provided additional data from its BETTER SLEEP clinical trial that it showcased in a poster presentation at the 16th World Sleep Congress 2022. World [...]

Nyxoah to Participate in the Oppenheimer 32nd Annual Healthcare Conference

Nyxoah to Participate in the Oppenheimer 32nd Annual Healthcare Conference

Mont-Saint-Guibert, Belgium, March 10 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will present at the Oppenheimer 32ndAnnual Healthcare Conference, which will be held virtually from March 15-17, [...]

Nyxoah to Present BETTER SLEEP Data, Host Physician Events at World Sleep Congress 2022

Nyxoah to Present BETTER SLEEP Data, Host Physician Events at World Sleep Congress 2022

Mont-Saint-Guibert, Belgium, March 7 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will showcase data from its BETTER SLEEP clinical trial in a poster presentation and host physician [...]

Nyxoah to Release Full Year 2021 Financial Results on March 24 and Host Conference Call on March 25, 2022

Nyxoah to Release Full Year 2021 Financial Results on March 24 and Host Conference Call on March 25, 2022

Mont-Saint-Guibert, Belgium, March 3 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the full year 2021 on Thursday, March 24, 2022, after the [...]